sintilimab,anlotinib
eli lilly,Innovent Biologics,advenchen,sino biopharmaceuticals
['biomarker', 'marker ']
encouraging data - but small study and a bit of an obsolete control arm in this era. hoping to see more biomarker data from this study and others. #esmo22 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him